Literature DB >> 8607906

American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis: comment on the article by Felson et al.

A van Gestel, P van Riel.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8607906     DOI： 10.1002/art.1780390325

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  7 in total

1.  Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use.

Authors:  Nobunori Takahashi; Takayoshi Fujibayashi; Daihei Kida; Yuji Hirano; Takefumi Kato; Daizo Kato; Kiwamu Saito; Atsushi Kaneko; Yuichiro Yabe; Hideki Takagi; Takeshi Oguchi; Hiroyuki Miyake; Tsuyoshi Watanabe; Masatoshi Hayashi; Yasuhide Kanayama; Koji Funahashi; Masahiro Hanabayashi; Shinya Hirabara; Shuji Asai; Toki Takemoto; Kenya Terabe; Nobuyuki Asai; Yutaka Yoshioka; Naoki Ishiguro; Toshihisa Kojima
Journal:  Rheumatol Int       Date:  2015-05-20       Impact factor: 2.631

2.  Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors.

Authors:  Regina Rendas-Baum; Gene V Wallenstein; Tamas Koncz; Mark Kosinski; Min Yang; John Bradley; Samuel H Zwillich
Journal:  Arthritis Res Ther       Date:  2011-02-16       Impact factor: 5.156

3.  Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity.

Authors:  Nobunori Takahashi; Toshihisa Kojima; Atsushi Kaneko; Daihei Kida; Yuji Hirano; Takayoshi Fujibayashi; Yuichiro Yabe; Hideki Takagi; Takeshi Oguchi; Hiroyuki Miyake; Takefumi Kato; Naoki Fukaya; Hisato Ishikawa; Masatoshi Hayashi; Seiji Tsuboi; Yasuhide Kanayama; Daizo Kato; Koji Funahashi; Hiroyuki Matsubara; Yosuke Hattori; Masahiro Hanabayashi; Shinya Hirabara; Kenya Terabe; Yutaka Yoshioka; Naoki Ishiguro
Journal:  Clin Rheumatol       Date:  2013-09-22       Impact factor: 2.980

4.  The efficacy and safety of the herbal medicine geonchildan for patients with active rheumatoid arthritis: study protocol for a randomized, double-blind, placebo-controlled, parallel pilot trial.

Authors:  Seunghoon Lee; Yeeun Cho; Jihye Kim; Jung Won Kang; Ga Young Yoon; Jun-Hwan Lee; So-Young Jung; Ojin Kwon; Kyung-Min Shin; Jae-Dong Lee
Journal:  Trials       Date:  2018-09-03       Impact factor: 2.279

5.  The agreement between ultrasound-determined joint inflammation and clinical signs in patients with rheumatoid arthritis.

Authors:  Xiaoying Sun; Xuerong Deng; Wenhui Xie; Liujun Wang; Yu Wang; Zhuoli Zhang
Journal:  Arthritis Res Ther       Date:  2019-04-17       Impact factor: 5.156

6.  Regulation of peripheral classical and non-classical monocytes on infliximab treatment in patients with rheumatoid arthritis and ankylosing spondylitis.

Authors:  Daniel Aeberli; Richard Kamgang; Deepak Balani; Willy Hofstetter; Peter M Villiger; Michael Seitz
Journal:  RMD Open       Date:  2016-01-04

7.  Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study.

Authors:  Yukimi Otsuka; Chikako Kiyohara; Yusuke Kashiwado; Takuya Sawabe; Shuji Nagano; Yasutaka Kimoto; Masahiro Ayano; Hiroki Mitoma; Mitsuteru Akahoshi; Yojiro Arinobu; Hiroaki Niiro; Koichi Akashi; Takahiko Horiuchi
Journal:  PLoS One       Date:  2018-04-25       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.